Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

No significant link between male pattern baldness and COVID-19 severity was found.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Public interest in hair loss increased during the COVID-19 pandemic.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

COVID-19 vaccines do not increase the risk of alopecia areata.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

A Chinese-Japanese boy had a rare fungal infection on his scalp and skin, likely caught in China.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Hantavirus survivors often face long-term health issues, needing ongoing care.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Age, health conditions, race, and gender affect COVID-19 risk.